Pappas Capital logo

Pappas Capital

North America, North Carolina, United States, Durham

Description

Bridging the Early-Stage Funding Gap.

Investor Profile

Pappas Capital has made 31 investments, with 2 in the past 12 months and 10% as lead.

Stage Focus

  • Series A (42%)
  • Series B (16%)
  • Series Unknown (16%)
  • Series C (13%)
  • Series D (6%)
  • Post Ipo Equity (6%)

Country Focus

  • United States (77%)
  • Singapore (10%)
  • Canada (6%)
  • China (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Software
  • Genetics
  • Artificial Intelligence (Ai)
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pappas Capital frequently co-invest with?

Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
CV
North America, Massachusetts, United States, Boston
Co-Investments: 5
CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 6
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 5
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 3
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 3
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 3
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3

Which angels does Pappas Capital often collaborate with?

Michael Gryseels
Asia, Singapore
Shared Deals: 1

What are some of recent deals done by Pappas Capital?

EarthOptics

Arlington, Virginia, United States

EarthOptics provides a cloud-based machine learning platform for soil and ground management.

AgricultureAgTechInformation TechnologyReal Time
Series UnknownNov 19, 2024
Amount Raised: $24,000,000
Enlaza Therapeutics

La Jolla, California, United States

Enlaza Therapeutics is a biotechnology research company.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AApr 30, 2024
Amount Raised: $100,000,000
RoboCT

Yuhang, Zhejiang, China

RoboCT is a developer of exoskeleton robot technology that helps patients with lower-body motor dysfunction learn to walk.

Artificial Intelligence (AI)Assistive TechnologyMedical DeviceRehabilitationRoboticsSoftware
Series UnknownOct 7, 2023
Veralox Therapeutics

Frederick, Maryland, United States

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownJun 20, 2023
Amount Raised: $24,000,000
Horizon Quantum Computing

Singapore, Central Region, Singapore

Horizon Quantum Computing builds software development tools to code, compile and deploy quantum applications from classical code.

ComputerHardwareQuantum ComputingSoftware
Series AMar 31, 2023
Amount Raised: $18,100,000
VFlow Tech

Singapore, Central Region, Singapore

VFlow uses its unique IP to build safe, long-lasting, high performing low-cost flow batteries for large scale energy storage application.

BatteryElectronicsEnergyEnergy StorageRenewable EnergySoftware
Series AFeb 7, 2023
Amount Raised: $10,000,000
Aktis Oncology

Boston, Massachusetts, United States

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

BiotechnologyHealth CareLife ScienceOncology
Series AAug 25, 2022
Amount Raised: $84,000,000
Yueer Gene

Yangpu, Hainan, China

Yueer is a genetic screening and diagnosis service provider focusing on applying genetic technology and international big data algorithms.

Big DataGeneticsHealth CareMedical
Series BJun 2, 2022
Amount Raised: $50,000,000
Us2.ai

Singapore, Central Region, Singapore

Us2.ai develops software and digital tools for echocardiography using artificial intelligence.

Artificial Intelligence (AI)Health CareMachine LearningMedicalMedical DevicemHealthSoftware
Series AApr 14, 2022
Amount Raised: $15,000,000
Plexium

San Diego, California, United States

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series BFeb 23, 2022
Amount Raised: $102,000,000